Eagle Pharmaceuticals, Inc. financial statements
Eagle Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2022
| Revenue | USD 316.61M | EODHD |
| Net income | USD 35.64M | EODHD |
| Cash and equivalents | USD 55.32M | EODHD |
| Total debt | USD 67.79M | EODHD |
Eagle Pharmaceuticals, Inc. financials on 6ix · Eagle Pharmaceuticals, Inc. on 6ix